Tags |
|
|
Links |
|
|
Main Subject - Wealth Networking-Move Smoothly Among Conversations
Smoothly end the conversation
You’ve had an enjoyable and informative conversation with someone at the event. Your conversational
You’ve had an enjoyable and informative conversation with someone at the event. Your conversational
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
partner has revealed reasons for attending the event and told you the biggest challenge in their business today. These reasons and their challenge
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
affect how you end the conversation.
If during your partner’s responses to your open-ended questions and encouragement, you hear some interesting
If during your partner’s responses to your open-ended questions and encouragement, you hear some interesting
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
hings but nothing related to your products or services, you can still leave them feeling good that they met and talked with you.
At an opportune p
At an opportune p
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
int in the conversation, you can repeat or rephrase what they told you was the biggest challenge in their business today. Then offer to keep this i
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
mind as you meet other people. Say that if you meet someone with a potential solution, you will be sure to introduce them to the other person. You
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
have now become their partner in problem solving, not just another stranger they will have difficulty remembering.
If your partner spent several m
If your partner spent several m
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
nutes telling you about a difficulty that you could help them with, you have an opportunity for your own company, but you mustn’t push yourself on
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
hem. The goal is to attract them to you.
At an opportune moment in the conversation, you could rephrase what they told you about their biggest cha
At an opportune moment in the conversation, you could rephrase what they told you about their biggest cha
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
lenge. It sounds like this: “It seems to me you are saying that you’re frustrated by…” Pause and they will nod in agreement.
Then you can ask if t
Then you can ask if t
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ey have done anything already to alleviate the problem, and follow up with questions such as “how did that work?” “Are you going to try something e
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
lse?” “What happens if you don’t fix this?”
At this point they are feeling that you care about them. You want to maintain this rather than swoopin
At this point they are feeling that you care about them. You want to maintain this rather than swoopin
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
in for a hard sell. You can casually mention that you’ve helped some of your clients address a similar problem, and simply mention one result. Les
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
is more in this case.
Your partner will probably ask you a bit about how you did it. Keep your response simple, and say that you offer a variety
Your partner will probably ask you a bit about how you did it. Keep your response simple, and say that you offer a variety
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
f approaches to this problem. This gives you the chance to then say, “You know, it’s been great talking with you. I’d be happy to continue this con
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ersation at your convenience, if you’d like. Would you like me to call you this week?”
If your partner says ‘yes’, then make a date for the phone
If your partner says ‘yes’, then make a date for the phone
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
all. If he says ‘no’ or evades with something like “I’m really busy” just accept that graciously. You have decided that you’re going to be an activ
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
member of this organization, so there will be other opportunities to meet this person again. You can always keep what you learned in the back of y
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ur mind, and mention it when you meet again to strengthen your connection with this person.
What about the ritual of exchanging business cards? We
What about the ritual of exchanging business cards? We
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
lth Networkers who avoid being Collectors or Givers have a carefully thought out method around business card exchanges. Details are in Chapter Five
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/31605/mainsubjects-Wealth-NetworkingMove-Smoothly-Among-Conversations.html">Wealth Networking-Move Smoothly Among Conversations</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/31605/mainsubjects-Wealth-NetworkingMove-Smoothly-Among-Conversations.html]Wealth Networking-Move Smoothly Among Conversations[/url]
Related Articles:
Creating a Fundraising Opportunities
Bookmark it:
|